2/12/25 13:59  | 2/11/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -10 | 28.54 | 0 | 0 | 0 | 84 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/30/25 12:01  | 1/29/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -11 | 29.52 | 0 | 0 | 0 | 84 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/23/25 15:23  | 1/22/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -42 | 30.43 | 0 | -1 | -2 | 85 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/21/25 15:59  | 1/17/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -37 | 29.96 | 0 | -1 | -1 | 86 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/14/25 16:10  | 1/13/25  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -46 | 28.70 | 0 | -2 | -3 | 59 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/19/24 16:03  | 3/18/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -564 | 56.90 | 0 | -10 | -15 | 55 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/13/24 16:38  | 2/12/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -40 | 67.77 | 0 | -1 | -1 | 65 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/31/24 16:18  | 1/29/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -24 | 64.14 | 0 | 0 | -1 | 65 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/23/24 18:01  | 1/22/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -90 | 65.00 | 0 | -1 | -2 | 66 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
1/17/24 16:41  | 1/16/24  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S.d | -109 | 66.81 | 0 | -2 | -2 | 67 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
10/24/23 16:18  | 10/23/23  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | Chief Bu | S | -6 | 46.04 | 0 | 0 | 0 | 52 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/18/22 16:02  | 8/17/22  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -348 | 69.50 | 0 | -5 | -15 | 29 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/12/22 16:58  | 8/11/22  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -335 | 67.00 | 0 | -5 | -15 | 29 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/8/22 16:02  | 8/4/22  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -608 | 60.75 | 0 | -10 | -25 | 29 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/28/22 16:03  | 7/27/22  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -285 | 57.00 | 0 | -5 | -15 | 29 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/21/22 16:31  | 7/19/22  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -282 | 56.42 | 0 | -5 | -15 | 29 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/21/22 16:11  | 6/16/22  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -418 | 41.79 | 0 | -10 | -25 | 29 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
4/22/22 17:35  | 4/20/22  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -368 | 52.53 | 0 | -7 | -20 | 28 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/22/21 16:24  | 7/21/21  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -65 | 65.00 | 0 | -1 | -10 | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/16/21 18:40  | 7/15/21  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -62 | 62.30 | 0 | -1 | -10 | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/16/21 16:32  | 6/15/21  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -260 | 64.96 | 0 | -4 | -30 | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/19/21 16:04  | 5/18/21  | APLS | Apellis Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Delong Mark Jeffrey | MA | O | SVP | S.d | -110 | 55.00 | 0 | -2 | -17 | 9 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |